References
1. Li X, Ostropolets A, Makadia R, et al. Characterising the background
incidence rates of adverse events of special interest for covid-19
vaccines in eight countries: multinational network cohort study.BMJ . 2021;373:n1435. doi:10.1136/bmj.n1435
2. COVID C, Team R. Allergic reactions including anaphylaxis after
receipt of the first dose of Moderna COVID-19 Vaccine—United States,
December 21, 2020–January 10, 2021. Morbidity and Mortality
Weekly Report . 2021;70(4):125.
3. Mohseni Afshar Z, Babazadeh A, Janbakhsh A, et al. Vaccine-induced
immune thrombotic thrombocytopenia after vaccination against Covid-19: A
clinical dilemma for clinicians and patients. Rev Med Virol . Jul
1 2021:e2273. doi:10.1002/rmv.2273
4. Ichikawa S, Kohata K, Okitsu Y, et al. Acquired hemophilia A with
sigmoid colon cancer: successful treatment with rituximab followed by
sigmoidectomy. Int J Hematol . Jul 2009;90(1):33-36.
doi:10.1007/s12185-009-0347-9
5. Hafzah H, McGuire C, Hamad A. A Case of Acquired Hemophilia A
Following SARS-CoV-2 Infection. Cureus . Jul 2021;13(7):e16579.
doi:10.7759/cureus.16579
6. Radwi M, Farsi S. A case report of acquired hemophilia following
COVID-19 vaccine. J Thromb Haemost . Jun 2021;19(6):1515-1518.
doi:10.1111/jth.15291
7. Farley S, Ousley R, Van Wagoner N, Bril F. Autoimmunity after
Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired
Hemophilia A. Thromb Haemost . Aug 5 2021;doi:10.1055/a-1579-5396
8. Cittone MG, Battegay R, Condoluci A, et al. The statistical risk of
diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2
vaccination. J Thromb Haemost . Sep 2021;19(9):2360-2362.
doi:10.1111/jth.15421
9. Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J.
Autoimmune- and complement-mediated hematologic condition recrudescence
following SARS-CoV-2 vaccination. Blood Adv . Jul 13
2021;5(13):2794-2798. doi:10.1182/bloodadvances.2021004957
10. Fueyo-Rodriguez O, Valente-Acosta B, Jimenez-Soto R, et al.
Secondary immune thrombocytopenia supposedly attributable to COVID-19
vaccination. BMJ Case Rep . May 31
2021;14(5)doi:10.1136/bcr-2021-242220
11. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia
including immune thrombocytopenia after receipt of mRNA COVID-19
vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).Vaccine . Jun 8 2021;39(25):3329-3332.
doi:10.1016/j.vaccine.2021.04.054
12. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following
Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol . May 1
2021;96(5):534-537. doi:10.1002/ajh.26132
13. Kim MA, Lee YW, Kim SR, et al. COVID-19 Vaccine-associated
Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI
Urticaria/Angioedema/Anaphylaxis Working Group. Allergy Asthma
Immunol Res . Jul 2021;13(4):526-544. doi:10.4168/aair.2021.13.4.526
14. Tanno LK, Castells M, Caminati M, Senna G, Demoly P. Anaphylaxis and
Coronavirus Disease 2019 vaccine: a danger relationship? Curr Opin
Allergy Clin Immunol . Oct 1 2021;21(5):411-417.
doi:10.1097/ACI.0000000000000778
15. Abi Zeid Daou C, Natout MA, El Hadi N. Biphasic anaphylaxis after
exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.J Med Virol . Oct 2021;93(10):6027-6029. doi:10.1002/jmv.27109
16. Cabanillas B, Akdis CA, Novak N. COVID-19 vaccine anaphylaxis: IgE,
complement or what else? A reply to: ”COVID-19 vaccine anaphylaxis: PEG
or not?”. Allergy . Jun 2021;76(6):1938-1940.
doi:10.1111/all.14725
17. Lee E, Lee YK, Kim TE, et al. Reports of anaphylaxis after
coronavirus disease 2019 vaccination, South Korea, 26 February to 30
April 2021. Euro Surveill . Aug
2021;26(33)doi:10.2807/1560-7917.ES.2021.26.33.2100694
18. Bahloul M, Ketata W, Lahyeni D, et al. Pulmonary capillary leak
syndrome following COVID-19 virus infection. J Med Virol . Jan
2021;93(1):94-96. doi:10.1002/jmv.26152
19. Wu MA, Fossali T, Pandolfi L, et al. Hypoalbuminemia in COVID-19:
assessing the hypothesis for underlying pulmonary capillary leakage.J Intern Med . Jun 2021;289(6):861-872. doi:10.1111/joim.13208
20. Case R, Ramaniuk A, Martin P, Simpson PJ, Harden C, Ataya A.
Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.Chest . Dec 2020;158(6):e267-e268. doi:10.1016/j.chest.2020.06.049
21. Matheny M, Maleque N, Channell N, et al. Severe Exacerbations of
Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case
Series. Ann Intern Med . Jun 15 2021;doi:10.7326/L21-0250
22. Choi GJ, Baek SH, Kim J, et al. Fatal Systemic Capillary Leak
Syndrome after SARS-COV-2Vaccination in Patient with Multiple Myeloma.Emerg Infect Dis . Aug 30 2021;27(11)doi:10.3201/eid2711.211723
23. Silva TF, Tomiotto-Pellissier F, Sanfelice RA, et al. A 21st Century
Evil: Immunopathology and New Therapies of COVID-19. Front
Immunol . 2020;11:562264. doi:10.3389/fimmu.2020.562264
24. Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after
COVID-19 vaccination. Lancet Rheumatol . Sep 2021;3(9):e617.
doi:10.1016/S2665-9913(21)00211-3
25. Negrea L, Rovin BH. Gross hematuria following vaccination for severe
acute respiratory syndrome coronavirus 2 in 2 patients with IgA
nephropathy. Kidney Int . Jun 2021;99(6):1487.
doi:10.1016/j.kint.2021.03.002
26. Rahim SEG, Lin JT, Wang JC. A case of gross hematuria and IgA
nephropathy flare-up following SARS-CoV-2 vaccination. Kidney
Int . Jul 2021;100(1):238. doi:10.1016/j.kint.2021.04.024
27. Sirufo MM, Raggiunti M, Magnanimi LM, Ginaldi L, De Martinis M.
Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral
Vector Vaccine: A Case Report. Vaccines . 2021;9(10):1078.
28. Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after
COVID-19 vaccination. The Lancet Rheumatology . 2021;3(9):e617.
29. Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, Rosmarin D.
Leukocytoclastic vasculitis flare following the COVID-19 vaccine.Int J Dermatol . Aug 2021;60(8):1032-1033. doi:10.1111/ijd.15623
30. Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis
after COVID-19 vaccine. Int J Dermatol . Oct
2021;60(10):1305-1306. doi:10.1111/ijd.15777
31. singh Arora K, Ariff M, Malik R, Kasar A, Patel C. COVID-19 Pfizer
Vaccine associated case of Leukocytoclastic vasculitis. Cureus
Journal of Medical Science . 2021;
32. Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID-19
vaccine-induced urticarial vasculitis. Dermatol Ther . Aug 8
2021:e15093. doi:10.1111/dth.15093
33. Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous
Vasculitis: Review on Diagnosis and Clinicopathologic Correlations.Clin Rev Allergy Immunol . Oct 2021;61(2):181-193.
doi:10.1007/s12016-020-08788-4
34. Vassallo C, Boveri E, Brazzelli V, et al. Cutaneous lymphocytic
vasculitis after administration of COVID-19 mRNA vaccine. Dermatol
Ther . Jul 30 2021:e15076. doi:10.1111/dth.15076
35. Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID-19
vaccination. The Lancet Rheumatology . 2021;
36. Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis
following vaccination with tetanus, influenza and hepatitis B vaccines
among persons 15–59 years of age. Vaccine .
2011;29(38):6592-6597.
37. Bixio R, Bertelle D, Masia M, Pistillo F, Carletto A, Rossini M.
Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019
Vaccination in Patients With Rheumatoid Arthritis in Remission.ACR Open Rheumatol . Sep 2 2021;doi:10.1002/acr2.11336
38. An QJ, Qin DA, Pei JX. Reactive arthritis after COVID-19
vaccination. Hum Vaccin Immunother . Sep 2 2021;17(9):2954-2956.
doi:10.1080/21645515.2021.1920274
39. Horino T. IgA nephropathy flare-up following SARS-CoV-2 vaccination.QJM . Aug 20 2021;doi:10.1093/qjmed/hcab223
40. Hanna C, Hernandez LPH, Bu L, et al. IgA nephropathy presenting as
macroscopic hematuria in 2 pediatric patients after receiving the Pfizer
COVID-19 vaccine. Kidney international . 2021;100(3):705-706.
41. Abramson M, Mon-Wei Yu S, Campbell KN, Chung M, Salem F. IgA
Nephropathy After SARS-CoV-2 Vaccination. Kidney Med . Sep-Oct
2021;3(5):860-863. doi:10.1016/j.xkme.2021.05.002
42. Plasse R, Nee R, Gao S, Olson S. Acute kidney injury with gross
hematuria and IgA nephropathy after COVID-19 vaccination. Kidney
Int . Oct 2021;100(4):944-945. doi:10.1016/j.kint.2021.07.020
43. Oyibo SO. Subacute Thyroiditis After Receiving the
Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).Cureus . Jun 2021;13(6):e16045. doi:10.7759/cureus.16045
44. Ratnayake GM, Dworakowska D, Grossman AB. Can COVID‐19 immunisation
cause subacute thyroiditis? Clinical Endocrinology . 2021;
45. Franquemont S, Galvez J. Subacute Thyroiditis After mRNA Vaccine for
Covid-19. Journal of the Endocrine Society . 2021;5(Suppl 1):A956.
46. Norouzi G. Subacute Thyroiditis Following COVID-19 Vaccination.Authorea Preprints . 2021;
47. İremli BG, Şendur SN, Ünlütürk U. Three Cases of Subacute
Thyroiditis Following SARS-CoV-2 Vaccine: Post-vaccination ASIA
Syndrome. The Journal of Clinical Endocrinology & Metabolism .
2021;
48. Stasiak M, Lewinski A. New aspects in the pathogenesis and
management of subacute thyroiditis. Rev Endocr Metab Disord . May
5 2021:1-13. doi:10.1007/s11154-021-09648-y
49. Sahin Tekin M, Saylisoy S, Yorulmaz G. Subacute thyroiditis
following COVID-19 vaccination in a 67-year-old male patient: a case
report. Hum Vaccin Immunother . Jul 1 2021:1-3.
doi:10.1080/21645515.2021.1947102
50. Girgis CM, Russo RR, Benson K. Subacute thyroiditis following the
H1N1 vaccine. J Endocrinol Invest . Jul-Aug 2010;33(7):506.
doi:10.1007/BF03346633
51. Altay FA, Guz G, Altay M. Subacute thyroiditis following seasonal
influenza vaccination. Hum Vaccin Immunother . Apr 2
2016;12(4):1033-4. doi:10.1080/21645515.2015.1117716
52. Toft J, Larsen S, Toft H. Subacute thyroiditis after hepatitis B
vaccination. Endocr J . Feb 1998;45(1):135.
53. Hsiao JY, Hsin SC, Hsieh MC, Hsia PJ, Shin SJ. Subacute thyroiditis
following influenza vaccine (Vaxigrip®) in a young female. The
Kaohsiung journal of medical sciences . 2006;22(6):297-300.
54. Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA
syndrome and endocrine autoimmune disorders. Best Pract Res Clin
Endocrinol Metab . Jan 2020;34(1):101412. doi:10.1016/j.beem.2020.101412
55. Bornemann C, Woyk K, Bouter C. Case Report: Two Cases of Subacute
Thyroiditis Following SARS-CoV-2 Vaccination. Front Med
(Lausanne) . 2021;8:737142. doi:10.3389/fmed.2021.737142
56. Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G,
Sanchez Valadez TI, Jara LJ. Two Cases of Graves’ Disease Following
SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by
Adjuvants. Thyroid . Sep 2021;31(9):1436-1439.
doi:10.1089/thy.2021.0142
57. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology
and use as a surgical aid in ophthalmology, and its therapeutic
potential in joint disease and wound healing. Drugs . Mar
1994;47(3):536-66. doi:10.2165/00003495-199447030-00009
58. Ghasemi S, Dashti M. Fight against COVID-19 with mRNA vaccines and
interaction with Dermal fillers. Clin Exp Vaccine Res . May
2021;10(2):151-153. doi:10.7774/cevr.2021.10.2.151
59. Michon A. Hyaluronic acid soft tissue filler delayed inflammatory
reaction following COVID-19 vaccination - A case report. J Cosmet
Dermatol . Sep 2021;20(9):2684-2690. doi:10.1111/jocd.14312
60. Nlandu YM, Makulo JR, Pakasa NM, et al. First Case of
COVID-19-Associated Collapsing Glomerulopathy in Sub-Saharan Africa.Case Rep Nephrol . 2020;2020:8820713. doi:10.1155/2020/8820713
61. Raza A, Estepa A, Chan V, Jafar MS. Acute Renal Failure in
Critically Ill COVID-19 Patients With a Focus on the Role of Renal
Replacement Therapy: A Review of What We Know So Far. Cureus . Jun
3 2020;12(6):e8429. doi:10.7759/cureus.8429
62. Lebedev L, Sapojnikov M, Wechsler A, et al. Minimal Change Disease
Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis .
Jul 2021;78(1):142-145. doi:10.1053/j.ajkd.2021.03.010
63. Lim JH, Han MH, Kim YJ, et al. New-onset Nephrotic Syndrome after
Janssen COVID-19 Vaccination: a Case Report and Literature Review.J Korean Med Sci . Aug 2 2021;36(30):e218.
doi:10.3346/jkms.2021.36.e218
64. Leclerc S, Royal V, Lamarche C, Laurin LP. Minimal Change Disease
With Severe Acute Kidney Injury Following the Oxford-AstraZeneca
COVID-19 Vaccine: A Case Report. Am J Kidney Dis . Oct
2021;78(4):607-610. doi:10.1053/j.ajkd.2021.06.008
65. Sanchez Tinajero A, Gonzalez Cueto E, Martinez Orozco JA, Becerril
Vargas E, Ruiz Santillan DP, Resendiz Escobar H. A 65-Year-Old Woman
with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day
History of Dry Cough and Fever Who Presented with Acute Renal Failure
Due to Infection with SARS-Cov-2. Am J Case Rep . Jul 25
2020;21:e926737. doi:10.12659/AJCR.926737
66. Eder M, Strassl R, Klager J, Aigner C, Thalhammer F, Kikic Z.
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in
a high-risk patient with minimal change disease. Wien Klin
Wochenschr . Apr 2021;133(7-8):412-413. doi:10.1007/s00508-020-01776-w
67. Su JR, Haber P, Ng CS, et al. Erythema multiforme, Stevens Johnson
syndrome, and toxic epidermal necrolysis reported after vaccination,
1999-2017. Vaccine . Feb 11 2020;38(7):1746-1752.
doi:10.1016/j.vaccine.2019.12.028
68. Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L.
Clinicopathologic correlations of COVID-19-related cutaneous
manifestations with special emphasis on histopathologic patterns.Clin Dermatol . Jan-Feb 2021;39(1):149-162.
doi:10.1016/j.clindermatol.2020.12.004
69. Bonino CB, Arias NM, Rico ML-P, et al. Atypical erythema multiforme
related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.International journal of dermatology .
2021;doi:https://doi.org/10.1111/ijd.15894
70. Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review
of epidemiology, pathogenesis, clinical features, and treatment.Dent Clin North Am . Oct 2013;57(4):583-96.
doi:10.1016/j.cden.2013.07.001
71. Clinic M. Chilblains. Mayo Clinic.
72. Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines:
What dermatologists should know? Dermatol Ther . Jul 7
2021;n/a(n/a):e15056. doi:10.1111/dth.15056
73. Pileri A, Guglielmo A, Raone B, Patrizi A. Chilblain lesions after
COVID-19 mRNA vaccine. Br J Dermatol . Jul 2021;185(1):e3.
doi:10.1111/bjd.20060
74. Temiz SA, Abdelmaksoud A, Dursun R, Vestita M. Acral chilblain-like
lesions following inactivated SARS-CoV-2 vaccination. Int J
Dermatol . Sep 2021;60(9):1152-1153. doi:10.1111/ijd.15619
75. Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P.
‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19
vaccine. Journal of Travel Medicine . 2021;28(4):taab024.
76. Piccolo V, Bassi A, Argenziano G, et al. BNT162b2 mRNA COVID‐19
vaccine‐induced chilblain‐like lesions reinforces the hypothesis of
their relationship with SARS‐CoV‐2. Journal of the European
Academy of Dermatology and Venereology . 2021;
77. D’Agostino V, Caranci F, Negro A, et al. A Rare Case of Cerebral
Venous Thrombosis and Disseminated Intravascular Coagulation Temporally
Associated to the COVID-19 Vaccine Administration. J Pers Med .
Apr 8 2021;11(4)doi:10.3390/jpm11040285
78. Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM.
Epidemiology, Pathophysiology, and Natural History of Pulmonary
Embolism. Semin Intervent Radiol . Jun 2018;35(2):92-98.
doi:10.1055/s-0038-1642036
79. Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein
thrombosis: a clinical review. J Blood Med . 2011;2:59-69.
doi:10.2147/JBM.S19009
80. Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune
thrombotic thrombocytopenia (VITT): Update on diagnosis and management
considering different resources. J Thromb Haemost . Jan
2022;20(1):149-156. doi:10.1111/jth.15572
81. Shakibajahromi B, Borhani-Haghighi A, Haseli S, Mowla A. Cerebral
venous sinus thrombosis might be under-diagnosed in the COVID-19 era.Eneurologicalsci . 2020;20
82. Shakibajahromi B, Borhani-Haghighi A, Ghaedian M, et al. Early,
delayed, and expanded intracranial hemorrhage in cerebral venous
thrombosis. Acta Neurol Scand . Dec 2019;140(6):435-442.
doi:10.1111/ane.13164
83. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and
radiological characteristics and predictors of outcome of cerebral
venous sinus thrombosis, a hospital-based study. Acta Neurol
Belg . Aug 2020;120(4):845-852. doi:10.1007/s13760-018-1009-6
84. Mowla A, Shakibajahromi B, Shahjouei S, et al. Cerebral venous sinus
thrombosis associated with SARS-CoV-2; a multinational case series.J Neurol Sci . Dec 15 2020;419:117183.
doi:10.1016/j.jns.2020.117183
85. Furie KL, Cushman M, Elkind MSV, Lyden PD, Saposnik G, American
Heart Association/American Stroke Association Stroke Council L.
Diagnosis and Management of Cerebral Venous Sinus Thrombosis With
Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke . Jul
2021;52(7):2478-2482. doi:10.1161/STROKEAHA.121.035564
86. Ostovan VR, Foroughi R, Rostami M, et al. Cerebral venous sinus
thrombosis associated with COVID-19: a case series and literature
review. J Neurol . Oct 2021;268(10):3549-3560.
doi:10.1007/s00415-021-10450-8
87. Vayne C, Nguyen T-H, Rollin J, et al. Characterization of new
monoclonal PF4-specific antibodies as useful tools for studies on
typical and autoimmune heparin-induced thrombocytopenia.Thrombosis and Haemostasis . 2021;121(03):322-331.
88. Cines DB, Bussel JB. SARS-CoV-2 vaccine–induced immune thrombotic
thrombocytopenia [published correction appears in N Engl J Med. 2021
Jun 10;384(23):e92]. N Engl J Med . 2021;384(23):2254-2256.
doi:10.1056/NEJMe2106315
89. Mehta PR, Apap Mangion S, Benger M, et al. Cerebral venous sinus
thrombosis and thrombocytopenia after COVID-19 vaccination - A report of
two UK cases. Brain Behav Immun . Jul 2021;95:514-517.
doi:10.1016/j.bbi.2021.04.006
90. Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of
COVID-19 vaccines administered in the EU: Should we be concerned?Toxicology Reports . 2021;8:871-879.
91. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger
S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.N Engl J Med . Jun 3 2021;384(22):2092-2101.
doi:10.1056/NEJMoa2104840
92. McCrae KR. Thrombotic thrombocytopenia due to SARS-CoV-2
vaccination. Cleveland Clinic Journal of Medicine . 2021;
93. Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P,
Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia
and cerebral venous sinus thrombosis post COVID-19 vaccination; a
systematic review. J Neurol Sci . Sep 15 2021;428:117607.
doi:10.1016/j.jns.2021.117607
94. Scully M, Singh D, Lown R, et al. Pathologic Antibodies to Platelet
Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med . Jun 10
2021;384(23):2202-2211. doi:10.1056/NEJMoa2105385
95. Committee PRA. COVID-19 Vaccine AstraZeneca: benefits still
outweigh the risks despite possible link to rare blood clots with low
blood platelets . 2021.
96. Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management
of vaccine-related thrombosis following AstraZeneca COVID-19
vaccination: guidance statement from the GTH. Hämostaseologie .
2021;
97. Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic Vein
Thrombosis: Current Perspectives. Vasc Health Risk Manag .
2019;15:449-461. doi:10.2147/VHRM.S197732
98. Aalberg JJ, Collins TP, Dobrow EM. Axillary lymphadenopathy in a
renal cell carcinoma patient after COVID-19 Vaccination. Radiol
Case Rep . Aug 2021;16(8):2164-2167. doi:10.1016/j.radcr.2021.05.031
99. Faermann R, Nissan N, Halshtok-Neiman O, et al. COVID-19 Vaccination
Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in
Israel: Analysis of 163 cases. Acad Radiol . Sep
2021;28(9):1191-1197. doi:10.1016/j.acra.2021.06.003
100. Mehta N, Sales RM, Babagbemi K, et al. Unilateral axillary
Adenopathy in the setting of COVID-19 vaccine. Clinical imaging .
2021;75:12-15.
101. Eifer M, Eshet Y. Imaging of COVID-19 Vaccination at FDG PET/CT.Radiology . 2021;299(2):E248-E248.
102. Özütemiz C, Krystosek LA, Church AL, et al. Lymphadenopathy in
COVID-19 vaccine recipients: diagnostic dilemma in oncology patients.Radiology . 2021:210275.
103. Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy
Following COVID-19 Vaccination: Imaging Findings Review. Acad
Radiol . Aug 2021;28(8):1058-1071. doi:10.1016/j.acra.2021.04.007
104. Pereira MP, Flores P, Neto AS. Neck and supraclavicular
lymphadenopathy secondary to 9-valent human papillomavirus vaccination.BMJ Case Rep . Nov 5 2019;12(11):e231582.
doi:10.1136/bcr-2019-231582
105. Barouni AS, Augusto C, Queiroz MV, Lopes MT, Zanini MS, Salas CE.
BCG lymphadenopathy detected in a BCG-vaccinated infant. Braz J
Med Biol Res . May 2004;37(5):697-700.
doi:10.1590/s0100-879x2004000500011
106. Katzir Z, Okon E, Ludmirski A, Sherman Y, Haas H. Generalized
lymphadenitis following BCG vaccination in an immunocompetent
12-year-old boy. European journal of pediatrics .
1984;141(3):165-167.
107. Shlamovitz GZ, Johar S. A case of Evans’ syndrome following
influenza vaccine. J Emerg Med . Feb 2013;44(2):e149-51.
doi:10.1016/j.jemermed.2012.01.060
108. Toy H, Karasoy D, Keser M. Lymphadenitis caused by H1N1
vaccination: case report. Vaccine . Mar 2 2010;28(10):2158-2160.
doi:10.1016/j.vaccine.2009.12.043
109. Sever JL, Brenner AI, Gale AD, et al. Safety of anthrax vaccine: an
expanded review and evaluation of adverse events reported to the Vaccine
Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug
Saf . Dec 2004;13(12):825-40. doi:10.1002/pds.936
110. Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky
N. Lymphadenopathy Associated With the COVID-19 Vaccine. Cureus .
Feb 23 2021;13(2):e13524. doi:10.7759/cureus.13524
111. Abou-Foul AK, Ross E, Abou-Foul M, George AP. Cervical
lymphadenopathy following COVID-19 vaccine: Clinical characteristics and
implications for head and neck cancer services. Authorea
Preprints . 2021;
112. Singh B, Kaur P, Kumar V, Maroules M. COVID-19 vaccine induced
Axillary and Pectoral Lymphadenopathy on PET scan. Radiol Case
Rep . Jul 2021;16(7):1819-1821. doi:10.1016/j.radcr.2021.04.053
113. Fernández-Prada M, Rivero-Calle I, Calvache-González A,
Martinón-Torres F. Acute onset supraclavicular lymphadenopathy
coinciding with intramuscular mRNA vaccination against COVID-19 may be
related to vaccine injection technique, Spain, January and February
2021. Eurosurveillance . 2021;26(10):2100193.
114. Tandon S, Shahab R, Benton JI, Ghosh SK, Sheard J, Jones TM.
Fine-needle aspiration cytology in a regional head and neck cancer
center: comparison with a systematic review and meta-analysis.Head Neck . Sep 2008;30(9):1246-52. doi:10.1002/hed.20849
115. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral
axillary lymphadenopathy detected on breast MRI in the era of
coronavirus disease (COVID-19) vaccination. American Journal of
Roentgenology . 2021;
116. Seely JM, Barry MH. The Canadian Society of Breast Imaging
Recommendations for the Management of Axillary Adenopathy in Patients
with Recent COVID-19 Vaccination - Update. Canadian Association of
Radiologists Journal . 2021;72(4):601-602. doi:10.1177/0846537121998949
117. Lehman CD, D’Alessandro HA, Mendoza DP, Succi MD, Kambadakone A,
Lamb LR. Unilateral Lymphadenopathy After COVID-19 Vaccination: A
Practical Management Plan for Radiologists Across Specialties. J
Am Coll Radiol . Jun 2021;18(6):843-852. doi:10.1016/j.jacr.2021.03.001
118. Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine
needle aspiration in COVID-19 vaccine-associated lymphadenopathy.Swiss Med Wkly . Jul 19 2021;151:w20557.
doi:10.4414/smw.2021.20557
119. Al Soub H, Ibrahim W, Al Maslamani M, Abbas G, Ummer W.
Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report.IDCases . 2021:e01253.
120. Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan
M. Kikuchi-Fujimoto Disease: analysis of 244 cases. Clin
Rheumatol . Jan 2007;26(1):50-4. doi:10.1007/s10067-006-0230-5
121. Watanabe T, Hashidate H, Hirayama Y, Iinuma Y. Kikuchi-Fujimoto
disease following vaccination against human papilloma virus infection
and Japanese encephalitis. Eur J Pediatr . Sep
2012;171(9):1409-11. doi:10.1007/s00431-012-1729-1
122. Podugu A, Kobe M. Kikuchi-Fujimoto Disease (KFD): A Rare Cause of
Fever and Lymphadenopathy Following Influenza Vaccination. Chest .
2013;144(4):230A.
123. Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 Recombinant
mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or
Coincidence? J Ophthalmic Vis Res . Jul-Sep 2021;16(3):490-501.
doi:10.18502/jovr.v16i3.9443
124. Turbeville SD, Cowan LD, Gass JD. Acute macular neuroretinopathy: a
review of the literature. Surv Ophthalmol . Jan-Feb
2003;48(1):1-11. doi:10.1016/s0039-6257(02)00398-3
125. Book BAJ, Schmidt B, Foerster AMH. Bilateral Acute Macular
Neuroretinopathy After Vaccination Against SARS-CoV-2. JAMA
Ophthalmol . Jul 1 2021;139(7):e212471.
doi:10.1001/jamaophthalmol.2021.2471
126. Bohler AD, Strom ME, Sandvig KU, Moe MC, Jorstad OK. Acute macular
neuroretinopathy following COVID-19 vaccination. Eye (Lond) . Jun
22 2021:1-2. doi:10.1038/s41433-021-01610-1
127. Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle
maculopathy and the organization of the retinal capillary plexuses.Prog Retin Eye Res . Mar 2021;81:100884.
doi:10.1016/j.preteyeres.2020.100884
128. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association
of Ocular Adverse Events With Inactivated COVID-19 Vaccination in
Patients in Abu Dhabi. JAMA Ophthalmol . Sep 2
2021;doi:10.1001/jamaophthalmol.2021.3477
129. Semeraro F, Morescalchi F, Russo A, et al. Central Serous
Chorioretinopathy: Pathogenesis and Management. Clin Ophthalmol .
2019;13:2341-2352. doi:10.2147/OPTH.S220845
130. Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS.
Acute-onset central serous retinopathy after immunization with COVID-19
mRNA vaccine. Am J Ophthalmol Case Rep . Sep 2021;23:101136.
doi:10.1016/j.ajoc.2021.101136
131. Subramony R, Lin LC, Knight DK, Aminlari A, Belovarski I. Bilateral
Retinal Detachments in a Healthy 22-year-old Female Following Moderna
SARS-CoV-2 Vaccination. The Journal of Emergency Medicine . 2021;
132. Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A.
Anterior uveitis onset after bnt162b2 vaccination: is this just a
coincidence? International Journal of Infectious Diseases .
2021;110:95-97.
133. Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following
Vaccination for COVID-19. Ocul Immunol Inflamm . May 19
2021;29(4):741-742. doi:10.1080/09273948.2021.1949478
134. Goyal M, Murthy SI, Annum S. Bilateral Multifocal Choroiditis
following COVID-19 Vaccination. Ocul Immunol Inflamm . May 19
2021;29(4):753-757. doi:10.1080/09273948.2021.1957123
135. Saraceno JJF, Souza GM, Dos Santos Finamor LP, Nascimento HM,
Belfort R, Jr. Vogt-Koyanagi-Harada Syndrome following COVID-19 and
ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous . Aug 30
2021;7(1):49. doi:10.1186/s40942-021-00319-3
136. Hong J, Chopra S, Kahn J, Kim B, Khemichian S. Autoimmune hepatitis
triggered by COVID-19. Intern Med J . 2021;51(7):1182-1183.
doi:10.1111/imj.15420
137. McShane C, Kiat C, Rigby J, Crosbie O. The mRNA COVID-19 vaccine -
A rare trigger of autoimmune hepatitis? J Hepatol . Jul 8
2021;doi:10.1016/j.jhep.2021.06.044
138. Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune
hepatitis following COVID vaccination. J Autoimmun . Sep
2021;123:102688. doi:10.1016/j.jaut.2021.102688
139. Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial Infarction:
Symptoms and Treatments. Cell Biochem Biophys . Jul
2015;72(3):865-7. doi:10.1007/s12013-015-0553-4
140. Chatterjee S, Ojha UK, Vardhan B, Tiwari A. Myocardial infarction
after COVID-19 vaccination-casual or causal? Diabetes Metab
Syndr . May-Jun 2021;15(3):1055-1056. doi:10.1016/j.dsx.2021.04.006
141. Boivin Z, Martin J. Untimely Myocardial Infarction or COVID-19
Vaccine Side Effect. Cureus . Mar 2 2021;13(3):e13651.
doi:10.7759/cureus.13651
142. Maadarani O, Bitar Z, Elzoueiry M, et al. Myocardial infarction
post COVID-19 vaccine–coincidence, Kounis syndrome or other
explanation–time will tell. JRSM open .
2021;12(8):20542704211025259.
143. Oakley CM. Myocarditis, pericarditis and other pericardial
diseases. Heart . Oct 2000;84(4):449-54.
doi:10.1136/heart.84.4.449
144. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19
Infection in People Under Age 20: A Population-Based Analysis.medRxiv . Jul 27 2021;doi:10.1101/2021.07.23.21260998
145. Luk A, Clarke B, Dahdah N, et al. Myocarditis and Pericarditis
following COVID-19 mRNA Vaccination: Practical Considerations for Care
Providers. Canadian Journal of Cardiology . 2021;
146. Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and
Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So
Far? Children . 2021;8(7):607.
147. Ramirez-Garcia A, Lozano Jimenez S, Darnaude Ximenez I, Gil Cacho
A, Aguado-Noya R, Segovia Cubero J. Pericarditis after administration of
the BNT162b2 mRNA COVID-19 vaccine. Rev Esp Cardiol (Engl Ed) .
Jul 16 2021;doi:10.1016/j.rec.2021.07.005
148. Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek
A. Myocarditis and Pericarditis After Vaccination for COVID-19.JAMA . Sep 28 2021;326(12):1210-1212. doi:10.1001/jama.2021.13443
149. Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S.
A Novel Case of Bifacial Diplegia Variant of Guillain-Barre Syndrome
Following Janssen COVID-19 Vaccination. Neurol Int . Aug 13
2021;13(3):404-409. doi:10.3390/neurolint13030040
150. Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barre syndrome
following COVID-19 vaccine. BMJ Case Rep . Jun 29
2021;14(6):e243629. doi:10.1136/bcr-2021-243629
151. Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barre
syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci . Aug 4
2021:1-2. doi:10.1007/s10072-021-05523-5
152. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological
complications of COVID-19: Guillain-Barre syndrome following Pfizer
COVID-19 vaccine. Cureus . 2021;13(2)
153. Introna A, Caputo F, Santoro C, et al. Guillain-Barre syndrome
after AstraZeneca COVID-19-vaccination: A causal or casual association?Clin Neurol Neurosurg . Sep 2021;208:106887.
doi:10.1016/j.clineuro.2021.106887
154. Scendoni R, Petrelli C, Scaloni G, Logullo FO.
Electromyoneurography and laboratory findings in a case of
Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine.Hum Vaccin Immunother . Aug 4 2021:1-4.
doi:10.1080/21645515.2021.1954826
155. McKean N, Chircop C. Guillain-Barre syndrome after COVID-19
vaccination. BMJ Case Rep . Jul 30 2021;14(7):e244125.
doi:10.1136/bcr-2021-244125
156. ChC E, Zeller J, Stingele R. Stroke: causes and classification.Hamostaseologie . 2006;26(4):298-308.
157. Markus HS. Ischaemic stroke can follow COVID-19 vaccination but is
much more common with COVID-19 infection itself. Journal of
Neurology, Neurosurgery & Psychiatry .
2021;doi:10.1136/jnnp-2021-327057
158. Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH,
Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and
bleeding in a patient newly vaccinated with an adenoviral vector-based
COVID-19 vaccine. J Thromb Haemost . Jul 2021;19(7):1771-1775.
doi:10.1111/jth.15347
159. Mason MC, Liaqat A, Morrow J, Basso R, Gujrati Y. Bilateral Facial
Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence?Cureus . Aug 2021;13(8):e17602. doi:10.7759/cureus.17602
160. Burrows A, Bartholomew T, Rudd J, Walker D. Sequential
contralateral facial nerve palsies following COVID-19 vaccination first
and second doses. BMJ Case Rep . Jul 19 2021;14(7):e243829.
doi:10.1136/bcr-2021-243829
161. Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of
Bell’s Palsy as the only major neurological manifestation in COVID-19
patients. Journal of Clinical Neuroscience . 2021;90:284-292.
162. Sato K, Mano T, Niimi Y, Toda T, Iwata A, Iwatsubo T. Facial nerve
palsy following the administration of COVID-19 mRNA vaccines: analysis
of a self-reporting database. Int J Infect Dis . Sep 4
2021;111:310-312. doi:10.1016/j.ijid.2021.08.071
163. Soeiro T, Salvo F, Pariente A, Grandvuillemin A, Jonville-Béra A-P,
Micallef J. Type I interferons as the potential mechanism linking mRNA
COVID-19 vaccines to Bell’s palsy. Therapie . 2021;
164. Tahir N, Koorapati G, Prasad S, et al. SARS-CoV-2
Vaccination-Induced Transverse Myelitis. Cureus . 2021;13(7)
165. Roman GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute
Transverse Myelitis (ATM):Clinical Review of 43 Patients With
COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse
Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol .
2021;12:653786. doi:10.3389/fimmu.2021.653786
166. Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S. Acute
transverse myelitis following SARS-CoV-2 vaccination: a case report and
review of literature. Journal of Neurology . 2021:1-12.
167. Group TMCW. Proposed diagnostic criteria and nosology of acute
transverse myelitis. Neurology 2002; 59: 499–505. QJM: An
International Journal of Medicine . 2020;
168. Pagenkopf C, Sudmeyer M. A case of longitudinally extensive
transverse myelitis following vaccination against Covid-19. J
Neuroimmunol . Sep 15 2021;358:577606.
doi:10.1016/j.jneuroim.2021.577606
169. Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal
extensive transverse myelitis following AstraZeneca COVID-19
vaccination. Clin Med (Lond) . Sep 2021;21(5):e535-e538.
doi:10.7861/clinmed.2021-0470